{{Rsnum
|rsid=1110277
|Gene=SLC23A2
|Chromosome=20
|position=4874036
|Orientation=plus
|GMAF=0.4027
|Gene_s=SLC23A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 48.2 | 45.5 | 6.2
| HCB | 53.3 | 39.4 | 7.3
| JPT | 63.7 | 28.3 | 8.0
| YRI | 8.2 | 36.3 | 55.5
| ASW | 14.0 | 47.4 | 38.6
| CHB | 53.3 | 39.4 | 7.3
| CHD | 63.2 | 35.8 | 0.9
| GIH | 43.6 | 41.6 | 14.9
| LWK | 0.9 | 31.2 | 67.9
| MEX | 42.1 | 40.4 | 17.5
| MKK | 6.4 | 44.2 | 49.4
| TSI | 35.3 | 51.0 | 13.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=24578608
|Title=Genetic Polymorphisms in SLC23A2 as Predictive Biomarkers of Severe Acute Toxicities after Treatment with a Definitive 5-Fluorouracil/Cisplatin-Based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma
|OA=1
}}

{{PMID Auto
|PMID=19243932
|Title=Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}